Pancreatic enzyme replacement therapy in subjects with exocrine pancreatic insufficiency and diabetes mellitus: a real-life, case–control study

Pancreatic enzyme replacement therapy in subjects with exocrine pancreatic insufficiency and diabetes mellitus: a real-life, case–control study

Abstract Background Exocrine pancreatic insufficiency (EPI) can be associated with all types of diabetes. Pancreatic enzyme replacement therapy (PERT) has short and long-term benefits in subjects with EPI, but its effects on diabetes control are uncertain. We aimed to study the effects of PERT initi...

Full description

Bibliographic Details
Main Authors: Laure Alexandre-Heymann, Fetta Yaker, Pierre Bel Lassen, Danièle Dubois-Laforgue, Etienne Larger
Format: Article
Language:English
Published: BMC 2024-02-01
Series:Diabetology & Metabolic Syndrome
Subjects:
Fecal elastase
Pancreatic enzyme replacement therapy
Exocrine pancreatic insufficiency
Diabetes
Online Access:https://doi.org/10.1186/s13098-024-01265-4

Internet

https://doi.org/10.1186/s13098-024-01265-4

Similar Items